About me

Director, Philadelphia VA Center of Excellence in Substance Addiction Treatment and Education (CESATE)
Professor of Psychiatry

My area of expertise is alcohol and drug use disorders. I provide individual treatment through the Charles O'Brien Center here at Penn, and I conduct research to develop and evaluate new interventions to facilitate and support long-term recovery from substance use disorders.

Education and training

Graduate School: Harvard University
Residency: Boston Medical Center
Fellowship: Massachusetts General Hospital

Insurance accepted

Aetna

Centivo

Claim Watcher (Homestead/INDECs)

Highmark Blue Shield

Humana Military (Tricare/Health Net Federal Services)

Imagine Health (Imagine Health 360)

Independence Blue Cross (IBC)

Magellan

Medicaid - New Jersey

Medicaid - Pennsylvania

Medicare - Pennsylvania

Oscar Health Plan of PA

PA Health & Wellness

Preferred Health Care/Eliance

Provider Partners Health Plan

Quest Behavioral Health

Rail Road Medicare/Palmetto GBA

VA Insurance (Veteran's CCN)

My Locations

Charles O'Brien Center for Addiction Treatment

5th Floor, Suite 500

3535 Market Street, Philadelphia, PA, 19104

866-301-4724

Learn about location

Penn Medicine hospital privileges

Hospital of the University of Pennsylvania: Advanced Practice Provider

Dr. McKay is a Penn Medicine provider.

Qualifications and experience

Memberships

Treatments and Conditions

My research

DePhilippis D, Khazanov G, Christofferson DE, Wesley CW, Burden JL, Liberto J, McKay JR. History and current status of contingency management programs in the Department of Veterans Affairs , Prev Med: 2023

Blanchard BE, Lynch KG, Malte CA, Hawkins EJ, DePhilippis D, Oslin DW, McKay JR, Saxon AJ. Towards shortening the Brief Addiction Monitor-Revised (BAM-R) , Drug Alcohol Depend Rep, 8: 2023,100183

Bhattacharya I, Johnson BA, Artman WJ, Wilson A, Lynch KG, McKay JR, Ertefaie A. A non-parametric Bayesian approach for adjusting partial compliance in sequential decision making , Stat Med, 42: 2023,2661-2691

Yap J, J Dziak J, Maiti R, Lynch K, McKay JR, Chakraborty B, Nahum-Shani I. Sample size estimation for comparing dynamic treatment regimens in a SMART: A Monte Carlo-based approach and case study with longitudinal overdispersed count outcomes , Stat Methods Med Res: 2023

Kelly PJ, Ingram I, Deane FP, Baker AL, Byrne G, Degan T, Osborne B, Meyer JM, Townsend C, Nunes J, McKay JR, Robinson L, Nolan E, Palazzi K, Lunn J. Feasibility and preliminary results of a call centre delivered continuing care intervention following residential alcohol and other drug treatment , Drug Alcohol Rev: 2023

Osilla KC, Gore KL, Pedersen ER, Hummer JF, DeYoreo M, Manuel JK, McKay JR, Kim JP, Nameth K. Study protocol for a sequential multiple assignment randomized trial to reduce risky drinking among service members and their partners , Contemp Clin Trials: 2023

French R, Worley J, Lowenstein M, Bogner HR, Calderbank T, DePhilippis D, Forrest A, Connolly Gibbons MB, Harris RA, Heywood S, Kampman K, Mandell DS, McKay JR, Newman ST, Oslin DW, Wadden S, Wolk CB. Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care , Fam Syst Health: 2023

Bhattacharya I, Ertefaie A, Lynch KG, McKay JR, Johnson BA. Nonparametric Bayesian Q-learning for optimization of dynamic treatment regimes in the presence of partial compliance , Stat Methods Med Res: 2023

Dugosh KL, Lent MR, Burkley SB, Millard CMK, McKay JR, Kampman KM. Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment , J Addict Med: 2023

Fivecoat HC, Lookatch SJ, Mavandadi S, McKay JR, Sayers SL. Social Factors Predict Treatment Engagement in Veterans with PTSD or SUD , J Behav Health Serv Res: 2023

View all publications